本页面由Tiger Trade Technology Pte. Ltd.提供服务

Checkmate Pharmaceuticals

10.50
0.0000
成交量:- -
成交额:66.80万
市值:2.31亿
市盈率:-3.60
高:10.50
开:10.50
低:10.50
收:10.50
52周最高:10.50
52周最低:2.00
股本:2,203.82万
流通股本:652.09万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.9195
每股收益(LYR):-2.8407
净资产收益率:-75.44%
总资产收益率:-42.31%
市净率:4.21
市盈率(LYR):-3.70

数据加载中...

2022/06/07

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/06/03

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/06/03

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/31

重要事件披露

8-K - Current report
2022/05/31

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/05/31

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/05/31

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/05/31

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/05/12

重要事件披露

8-K - Current report
2022/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/11

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/04/29

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/04/19

重要事件披露

8-K - Current report
2022/04/19

重要事件披露

8-K - Current report
2022/03/30

重要事件披露

8-K - Current report
2022/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/01

重要事件披露

8-K - Current report